Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 41

Sort by

Sort Order Select

Journal Articles

Use of Statins, Survival and Incidence of Thrombosis Among Older Adults with Essential Thrombocythemia: A Population-Based Study

Nikolai Podoltsev, MD PhD, Mengxin Zhu, MPH, Rong Wang, PhD, Amer M. Zeidan, MBBS, MHS, Xiaoyi Wang, MD MPH, Scott F Huntington, MD MPH, Smith Giri, MBBS, Amy J. Davidoff, PhD MS, Steven D. Gore, MD, Xiaomei Ma, PhD

Blood (2018) 132 (Supplement 1): 4865.

https://doi.org/10.1182/blood-2018-99-119118

Published: 2018

Journal Articles

Atorvastatin Restored the CD4 + T Cell Homeostasis By Regulating the Axis of Effector T Cells and Regulatory T Cells in Immune Thrombocytopenia

Pengcheng Xu, Yajing Zhao, BA, MD, Ming Hou, MD, Panpan Han

Blood (2018) 132 (Supplement 1): 132.

https://doi.org/10.1182/blood-2018-99-114690

Published: 2018

Journal Articles

Atorvastatin enhances bone marrow endothelial cell function in corticosteroid-resistant immune thrombocytopenia patients

Yuan Kong, Xie-Na Cao, Xiao-Hui Zhang, Min-Min Shi, Yue-Yun Lai, Yu Wang, Lan-Ping Xu, Ying-Jun Chang, Xiao-Jun Huang

Blood (2018) 131 (11): 1219–1233.

https://doi.org/10.1182/blood-2017-09-807248

Published: 2018

Includes: Supplemental data

Journal Articles

Atorvastatin May Reverse Corticosteroid-Resistant Immune Thrombocytopenia Via Improving Impaired Bone Marrow Endothelial Cells

Yuan Kong, Xie-Na Cao, Xiaohui Zhang, MD, Min-Min Shi, Yue-Yun Lai, Yu Wang, Lan-Ping Xu, Ying-Jun Chang, Xiao-Jun Huang, MD

Blood (2017) 130 (Supplement 1): 232.

https://doi.org/10.1182/blood.V130.Suppl_1.232.232

Published: 2017

Journal Articles

Atorvastatin As an Adjunct Therapy in Patients with Acute Venous Thromboembolism

Tzu-Fei Wang, MD, Melanie Heinlein, Amanda P. Waller, PhD, Lai Wei, PhD, Bryce A. Kerlin, MD

Blood (2017) 130 (Supplement 1): 1099.

https://doi.org/10.1182/blood.V130.Suppl_1.1099.1099

Published: 2017

Journal Articles

KRAS G12D expression in lung-resident myeloid cells promotes pulmonary LCH-like neoplasm sensitive to statin treatment

Tamihiro Kamata, Susan Giblett, Catrin Pritchard

Blood (2017) 130 (4): 514–526.

https://doi.org/10.1182/blood-2017-02-770149

Published: 2017

Includes: Supplemental data

Journal Articles

KRAS G12D , pulmonary LCH, and atorvastatin

Achille Aouba

Blood (2017) 130 (4): 391–392.

https://doi.org/10.1182/blood-2017-06-788455

Published: 2017

Journal Articles

Atorvastatin enhances endothelial cell function in posttransplant poor graft function

Min-Min Shi, Yuan Kong, Yang Song, Yu-Qian Sun, Yu Wang, Xiao-Hui Zhang, Lan-Ping Xu, Kai-Yan Liu, Xiao-Jun Huang

Blood (2016) 128 (25): 2988–2999.

https://doi.org/10.1182/blood-2016-03-702803

Published: 2016

Journal Articles

Ponatinib and Cardiovascular Complications

Alvin H. Schmaier, MD, Alona A. Merkulova, M.S., Steven Mitchell, Evi X Stavrou, MD

Blood (2016) 128 (22): 3055.

https://doi.org/10.1182/blood.V128.22.3055.3055

Published: 2016

Journal Articles

Dysfunction of Bone Marrow Endothelial Progenitor Cells from Subjects with Poor Graft Function Following Allogeneic Hematopoietic Stem Cell Transplantation Can be Improved By Atorvastatin

Minmin Shi, Yuan Kong, MD PhD, Yang Song, Yuqian Sun, Yu Wang, Xiaohui Zhang, Lanping Xu, Kaiyan Liu, Xiaojun Huang

Blood (2016) 128 (22): 3386.

https://doi.org/10.1182/blood.V128.22.3386.3386

Published: 2016

Journal Articles

Early Mycosis Fungoides Lesions with Increased CD3-CD4+ Histiocytes Are Associated with Dyslipidemia and Use of Statins

Chee Won Oh, MD PhD, Carlos Torres-Cabala, MD, Mikyoung Chang, PhD, Madeleine Duvic, MD

Blood (2015) 126 (23): 4609.

https://doi.org/10.1182/blood.V126.23.4609.4609

Published: 2015

Journal Articles

Efficacy and Safety of Four Factor Prothrombin Complex Concentrates As a Reversal Agent for Oral Xa Inhibitors

Krishna Gundabolu, MD, Brian Trevarrow, BA, Pharm.D., BCPS, Scott A Koepsell, MD, PhD, FCAP

Blood (2015) 126 (23): 4668.

https://doi.org/10.1182/blood.V126.23.4668.4668

Published: 2015

Journal Articles

Long Term Statin Use and Risk of Multiple Myeloma Among 15.5 Million Taiwanese Adults: A Retrospective Cohort Study

Brian C.-H. Chiu, PhD, Jin-Hua Chen, PhD, Yu-Chun Yen, MS, Gregory S. Calip, PharmD, MPH, PhD, Chun-Ru Chien, MD PhD, Habibul Ahsan, MD MMedSc, Ya-Chen T Shih, PhD, Kuang-Fu Cheng, PhD

Blood (2015) 126 (23): 4198.

https://doi.org/10.1182/blood.V126.23.4198.4198

Published: 2015

Journal Articles

Successful Treatment of HU-Refractory Polycythemia Vera with Atorvastatin and Low Dose Hydroxyurea. Results from a Pilot Study in Bolivia

Ricardo Amaru, MD, Ariel Amaru, MD, Hortensia Miguez, Gina Torres, Josue Mamani, Maria Aguilar, Heriberto Cuevas

Blood (2015) 126 (23): 5621.

https://doi.org/10.1182/blood.V126.23.5621.5621

Published: 2015

Journal Articles

Impact of Atorvastatin on Cellular Immunome of Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation (AHSCT)

Yvonne A Efebera, MD, Susan Geyer, PhD, Anissa Bingman, M.S., Rhonda Kitzler, BS, Patrick Elder, MS, Leslie A. Andritsos, MD, Samantha M. Jaglowski, MD MPH, Sumithira Vasu, MBBS, William Blum, MD, Rebecca B. Klisovic, MD, Sam Penza, MD, Kevin Coombes, PhD, Craig C Hofmeister, MD MPH, Don Benson, MD PhD, Steven M. Devine, MD, Gerard Lozanski, MD

Blood (2014) 124 (21): 1166.

https://doi.org/10.1182/blood.V124.21.1166.1166

Published: 2014

Journal Articles

The Use of Statin Enhances Chance of Achieving MR4.5 in Chronic Myeloid Leukemia Patients in Chronic Phase Following Imatinib Therapy

Dennis Dong Hwan Kim, MDPhD, Feras Alfraih, MD, Honggi Lee, MD, Jeffrey H. Lipton, MD PhD

Blood (2014) 124 (21): 1804.

https://doi.org/10.1182/blood.V124.21.1804.1804

Published: 2014

Journal Articles

Phase II Trial Evaluating the Safety and Efficacy of Atorvastatin for the Prophylaxis of Acute Graft Vs. Host Disease (aGVHD) in Patients with Hematological Malignancies Undergoing HLA-Matched Related Donor Allogeneic Hematopoietic Stem Cell Transplantation (allo HSCT)

Yvonne A Efebera, MD, Susan Geyer, PhD, Anissa Bingman, M.S., Patrick Elder, MS, Rhonda Kitzler, BS, Kevin Coombes, PhD, Carrie Hennelly, MA, Katie Cortright, BS, Leslie A. Andritsos, MD, Samantha M. Jaglowski, MD MPH, Sumithira Vasu, MBBS, William Blum, MD, Rebecca B. Klisovic, MD, Sam Penza, MD, Craig C Hofmeister, MD MPH, Don M Benson, MD PhD, Gerard Lozanski, MD, Steven M. Devine, MD

Blood (2014) 124 (21): 3929.

https://doi.org/10.1182/blood.V124.21.3929.3929

Published: 2014

Journal Articles

Tissue Factor-Dependent Pro-Coagulant Activity Of Human Platelets Is Directly Related To Membrane Cholesterol Content. Rosuvastatin, But Not Atorvastatin, Reduces The Platelet Cholesterol, Tissue Factor Protein and Clotting Activity In Hypercholesterolemic Patients

Olga Panes, Juan P. Valderas, M.D., Mónica Acevedo, M.D., Susana Contreras, Jaime Pereira, M.D., Attilio Rigotti, M.D., PhD., Diego Mezzano, M.D.

Blood (2013) 122 (21): 34.

https://doi.org/10.1182/blood.V122.21.34.34

Published: 2013

Journal Articles

Dissecting The Effects Of Isoprenoid Pathway Inhibition On Hemostasis and Thrombosis: Differential Effects Of Atorvastatin and Digeranyl Bisphosphonate In Hypercholesterolemic Mice

Neha Bhasin, MD, Jeff Stevens, PhD, Masaru Niki, MD, PhD, Huaxiang Tong, PhD, Craig Kuder, PhD, Raymond J. Hohl, MD, PhD, Steven R Lentz, MD, PhD

Blood (2013) 122 (21): 2378.

https://doi.org/10.1182/blood.V122.21.2378.2378

Published: 2013

Journal Articles

Prospective Analysis Of Statin Use and Risk Of Non-Hodgkin’s Lymphoma In The Women’s Health Initiative Cohort

Pinkal Desai, Robert Wallace, Matthew Anderson, Abdel Alqwasmi, Barbara V. Howard, Chunyuan Wu, Monica Safford, Lisa W. Martin, Nicolas Schlecht, Simin Liu, Jeremy Cetnar, Dominic Cirillo, Allison Jay, JoAnn E. Manson, Michael S. Simon

Blood (2013) 122 (21): 4279.

https://doi.org/10.1182/blood.V122.21.4279.4279

Published: 2013

NARROW

Use of Statins, Survival and Incidence of Thrombosis Among Older Adults with Essential Thrombocythemia: A Population-Based Study

Atorvastatin Restored the CD4 + T Cell Homeostasis By Regulating the Axis of Effector T Cells and Regulatory T Cells in Immune Thrombocytopenia

Atorvastatin enhances bone marrow endothelial cell function in corticosteroid-resistant immune thrombocytopenia patients

Atorvastatin May Reverse Corticosteroid-Resistant Immune Thrombocytopenia Via Improving Impaired Bone Marrow Endothelial Cells

Atorvastatin As an Adjunct Therapy in Patients with Acute Venous Thromboembolism

KRAS G12D expression in lung-resident myeloid cells promotes pulmonary LCH-like neoplasm sensitive to statin treatment

KRAS G12D , pulmonary LCH, and atorvastatin

Atorvastatin enhances endothelial cell function in posttransplant poor graft function

Ponatinib and Cardiovascular Complications

Dysfunction of Bone Marrow Endothelial Progenitor Cells from Subjects with Poor Graft Function Following Allogeneic Hematopoietic Stem Cell Transplantation Can be Improved By Atorvastatin

Early Mycosis Fungoides Lesions with Increased CD3-CD4+ Histiocytes Are Associated with Dyslipidemia and Use of Statins

Efficacy and Safety of Four Factor Prothrombin Complex Concentrates As a Reversal Agent for Oral Xa Inhibitors

Long Term Statin Use and Risk of Multiple Myeloma Among 15.5 Million Taiwanese Adults: A Retrospective Cohort Study

Successful Treatment of HU-Refractory Polycythemia Vera with Atorvastatin and Low Dose Hydroxyurea. Results from a Pilot Study in Bolivia

Impact of Atorvastatin on Cellular Immunome of Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation (AHSCT)

The Use of Statin Enhances Chance of Achieving MR4.5 in Chronic Myeloid Leukemia Patients in Chronic Phase Following Imatinib Therapy

Phase II Trial Evaluating the Safety and Efficacy of Atorvastatin for the Prophylaxis of Acute Graft Vs. Host Disease (aGVHD) in Patients with Hematological Malignancies Undergoing HLA-Matched Related Donor Allogeneic Hematopoietic Stem Cell Transplantation (allo HSCT)

Tissue Factor-Dependent Pro-Coagulant Activity Of Human Platelets Is Directly Related To Membrane Cholesterol Content. Rosuvastatin, But Not Atorvastatin, Reduces The Platelet Cholesterol, Tissue Factor Protein and Clotting Activity In Hypercholesterolemic Patients

Dissecting The Effects Of Isoprenoid Pathway Inhibition On Hemostasis and Thrombosis: Differential Effects Of Atorvastatin and Digeranyl Bisphosphonate In Hypercholesterolemic Mice

Prospective Analysis Of Statin Use and Risk Of Non-Hodgkin’s Lymphoma In The Women’s Health Initiative Cohort

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only